- Filed
- Apr 24, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Mar 28, 2026 | 32.1M sh |
| Shares Diluted | Q2 2026 · Mar 28, 2026 | 32.07M sh |
| Shares Diluted | Q2 2026 · Mar 29, 2025 | 31.94M sh |
| Shares Diluted | Q2 2026 · Mar 29, 2025 | 32.17M sh |
| Stock Repurchased | Q2 2026 · Mar 28, 2026 | $50.43M |
| Stock Repurchased | Q2 2026 · Mar 29, 2025 | $126.43M |
| Dividends Paid | Q2 2026 · Mar 28, 2026 | $18.71M |
| Dividends Paid | Q2 2026 · Mar 29, 2025 | $18.11M |
| Capex | Q2 2026 · Mar 28, 2026 | $66.18M |
| Capex | Q2 2026 · Mar 29, 2025 | $70.38M |
| Operating Cash Flow | Q2 2026 · Mar 28, 2026 | $84.83M |
| Operating Cash Flow restated | Q2 2026 · Mar 29, 2025 | −$92.89M |
| Long Term Debt | Q2 2026 · Mar 28, 2026 | $739.83M |
| Long Term Debt | Q2 2026 · Sep 27, 2025 | $944.12M |
| Cash And Equivalents | Q2 2026 · Mar 28, 2026 | $307.55M |
| Cash And Equivalents | Q2 2026 · Sep 27, 2025 | $62.01M |
| Stockholders Equity | Q2 2026 · Mar 28, 2026 | $2.1B |
| Stockholders Equity | Q2 2026 · Sep 27, 2025 | $1.99B |
| Stockholders Equity restated | Q2 2026 · Mar 29, 2025 | $1.81B |
| Current Liabilities | Q2 2026 · Mar 28, 2026 | $1.67B |
| Current Liabilities | Q2 2026 · Sep 27, 2025 | $1.12B |
| Total Liabilities | Q2 2026 · Mar 28, 2026 | $2.8B |
| Total Liabilities | Q2 2026 · Sep 27, 2025 | $2.43B |
| Current Assets | Q2 2026 · Mar 28, 2026 | $2.79B |
| Current Assets | Q2 2026 · Sep 27, 2025 | $2.37B |
| Total Assets | Q2 2026 · Mar 28, 2026 | $4.9B |
| Total Assets | Q2 2026 · Sep 27, 2025 | $4.43B |
| Eps Diluted | Q2 2026 · Mar 28, 2026 | $2.55 |
| Eps Diluted | Q2 2026 · Mar 28, 2026 | $5.01 |
| Eps Diluted restated | Q2 2026 · Mar 29, 2025 | $1.71 |
| Eps Diluted restated | Q2 2026 · Mar 29, 2025 | $3.49 |
| Eps Basic | Q2 2026 · Mar 28, 2026 | $2.58 |
| Eps Basic | Q2 2026 · Mar 28, 2026 | $5.07 |
| Eps Basic restated | Q2 2026 · Mar 29, 2025 | $1.73 |
| Eps Basic restated | Q2 2026 · Mar 29, 2025 | $3.53 |
| Sga Expense | Q2 2026 · Mar 28, 2026 | $136.32M |
| Sga Expense | Q2 2026 · Mar 28, 2026 | $285.28M |
| Sga Expense restated | Q2 2026 · Mar 29, 2025 | $133.93M |
| Sga Expense restated | Q2 2026 · Mar 29, 2025 | $262.07M |
| Rd Expense | Q2 2026 · Mar 28, 2026 | $26.66M |
| Rd Expense | Q2 2026 · Mar 28, 2026 | $51.3M |
| Rd Expense | Q2 2026 · Mar 29, 2025 | $24.48M |
| Rd Expense | Q2 2026 · Mar 29, 2025 | $48.09M |
| Net Income | Q2 2026 · Mar 28, 2026 | $81.84M |
| Net Income | Q2 2026 · Mar 28, 2026 | $160.69M |
| Net Income restated | Q2 2026 · Mar 29, 2025 | $54.61M |
| Net Income restated | Q2 2026 · Mar 29, 2025 | $112.14M |
| Operating Income | Q2 2026 · Mar 28, 2026 | $137.94M |
| Operating Income | Q2 2026 · Mar 28, 2026 | $273.38M |
| Operating Income restated | Q2 2026 · Mar 29, 2025 | $109.05M |
| Operating Income restated | Q2 2026 · Mar 29, 2025 | $212.66M |
| Gross Profit | Q2 2026 · Mar 28, 2026 | $287.56M |
| Gross Profit | Q2 2026 · Mar 28, 2026 | $581.8M |
| Gross Profit restated | Q2 2026 · Mar 29, 2025 | $256.62M |
| Gross Profit restated | Q2 2026 · Mar 29, 2025 | $501.7M |
| Cost Of Revenue | Q2 2026 · Mar 28, 2026 | $764.39M |
| Cost Of Revenue | Q2 2026 · Mar 28, 2026 | $1.57B |
| Cost Of Revenue restated | Q2 2026 · Mar 29, 2025 | $675.26M |
| Cost Of Revenue restated | Q2 2026 · Mar 29, 2025 | $1.34B |
| Revenue | Q2 2026 · Mar 28, 2026 | $1.05B |
| Revenue | Q2 2026 · Mar 28, 2026 | $2.15B |
| Revenue restated | Q2 2026 · Mar 29, 2025 | $934.02M |
| Revenue restated | Q2 2026 · Mar 29, 2025 | $1.84B |